전체 < 기사목록

GI Innovation wins substance patent of immunotherapy GI-101 in US
Bio Kim Chan-hyuk 06.28 13:15
‘Pharmaceutical industry can hardly move forward without API sector’s growth’
Pharma Kim Chan-hyuk 06.27 17:31
‘Government to approve SK Bioscience’s Covid-19 vaccine this week’
Policy Kim Chan-hyuk 06.27 15:11
Expectations rise for vaccine sovereignty as government includes related tech into core strategy technology
Pharma Kim Chan-hyuk 06.27 12:39
Korea OKed lot release for 170 million doses of Covid-19 vaccines in 2021
Policy Kim Chan-hyuk 06.24 15:03
Korean biosimilars need to show more than just cost-saving benefit
Bio Kim Chan-hyuk 06.24 14:20
Kolon cancels flu drug permit voluntarily after illegal drug donation controversy
Pharma Kim Chan-hyuk 06.23 12:33
Pharmacists vow all-out war against OTC drug vending machines
Device/ICT Kim Chan-hyuk 06.21 15:39
Samsung Bioepis, Samil to sell Lucentis biosimilar together
Bio Kim Chan-hyuk 06.21 15:37
SK Bioscience shares slide on slow vaccine development
Bio Kim Chan-hyuk 06.20 15:00
WTO’s IP waiver for Covid-19 vaccines may affect Korean firms negatively
Pharma Kim Chan-hyuk 06.20 12:42
Korean drug companies rush to secure LNP technology
Pharma Kim Chan-hyuk 06.17 11:59
Drugmakers release sustainability reports to prepare for ESG evaluation
Pharma Kim Chan-hyuk 06.16 11:53
Curocell’s CAR-T therapy shows 82% complete remission in phase 1 study
Bio Kim Chan-hyuk 06.15 12:14
Shinpoong starts new phase 2 trial of Pyramax in Korea
Pharma Kim Chan-hyuk 06.14 12:10
Experts to talk on regulatory science in bio-health industry
Policy Kim Chan-hyuk 06.13 12:17
Hanall Biopharma’s US partner to expand batoclimab’s indications
Bio Kim Chan-hyuk 06.10 15:28
EMA’s critical Covid-19 medicines include Celltrion’s Regkirona
Pharma Kim Chan-hyuk 06.10 14:02
Vuno’s AI-based 3D brain MRI device scores insurance benefit
Device/ICT Kim Chan-hyuk 06.09 15:18
TiumBio eyes global partnership at 2022 BIO USA
Bio Kim Chan-hyuk 06.09 15:16

상단영역

본문영역

All Articles 목록 ( 총 : 559)

기사목록 보기 형태

GI Innovation wins substance patent of immunotherapy GI-101 in US

‘Pharmaceutical industry can hardly move forward without API sector’s growth’

‘Government to approve SK Bioscience’s Covid-19 vaccine this week’

Expectations rise for vaccine sovereignty as government includes related tech into core strategy technology

Korea OKed lot release for 170 million doses of Covid-19 vaccines in 2021

Korean biosimilars need to show more than just cost-saving benefit

Kolon cancels flu drug permit voluntarily after illegal drug donation controversy

Pharmacists vow all-out war against OTC drug vending machines

Samsung Bioepis, Samil to sell Lucentis biosimilar together

SK Bioscience shares slide on slow vaccine development

WTO’s IP waiver for Covid-19 vaccines may affect Korean firms negatively

Korean drug companies rush to secure LNP technology

Drugmakers release sustainability reports to prepare for ESG evaluation

Curocell’s CAR-T therapy shows 82% complete remission in phase 1 study

Shinpoong starts new phase 2 trial of Pyramax in Korea

Experts to talk on regulatory science in bio-health industry

Hanall Biopharma’s US partner to expand batoclimab’s indications

EMA’s critical Covid-19 medicines include Celltrion’s Regkirona

Vuno’s AI-based 3D brain MRI device scores insurance benefit

TiumBio eyes global partnership at 2022 BIO USA